Hromas et al., however, claimed that CCR7 ligands, CCL19 and CCL21, and a CCR6 ligand, CCL20, inhibited proliferation of CML progenitor cells as well as normal progenitor cells [101]. Here, CCL20 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.